Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Previous years tags : Colorectal cancer save search
Mainz Biomed and Partners Join International Awareness Campaign for Colorectal Cancer Awareness Month
Published: 2022-03-02 (Crawled : 09:00) - globenewswire.com
MYNZ | $0.89 -1.55% 33K
|
|
| O: 1.61%
H: 3.95%
C: 1.27%
cancer colorectal cancer
Cottonelle® and BLKHLTH® Recommit to Addressing Stigmas to Black Americans and Colorectal Cancer Screenings with Year Two of GoodDownThere Campaign
Published: 2022-03-01 (Crawled : 13:30) - prnewswire.com
KMB | $126.21 0.48% 1.2M
|
Consumer Non-Durables
|
| O: -0.28%
H: 0.61%
C: -0.8%
cottonelle america one cancer colorectal cancer
Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings
Published: 2022-03-01 (Crawled : 12:30) - prnewswire.com
BHC | $8.63 0.35% 1.5M
|
Health Technology
|
| O: -0.63%
H: 0.84%
C: -1.64%
blue cancer colorectal cancer
Landmark CIRCULATE-Japan Study Shows Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer
Published: 2022-01-22 (Crawled : 20:20) - prnewswire.com
NTRA S | $84.22 -3.51% 730K
|
Health Services
| Email alert
Add to watchlist
test therapy cancer colorectal cancer
Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas
Published: 2022-01-20 (Crawled : 20:00) - biospace.com/
VNRX | $0.619 0.29% 180K
|
Health Technology
|
| O: 1.36%
H: 1.0%
C: -1.67%
risk leo asco cancer colorectal cancer
Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
CRDF | $4.36 -0.23% 240K
|
Health Services
|
| O: -3.35%
H: 0.0%
C: 0.0%
ces pons cancer colorectal cancer
Exelixis Announces Detailed Results for Cabozantinib in Combination with Immunotherapies in Patients with Advanced Colorectal Cancer at ASCO GI 2022
Published: 2022-01-18 (Crawled : 01:00) - biospace.com/
TAK | News | $13.185 0.19% 430K
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
EXEL | $22.28 -0.93% 960K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
asco cancer colorectal cancer immunotherapy
Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients
Published: 2022-01-18 (Crawled : 23:00) - prnewswire.com
EXAS | $61.67 -2.85% 700K
|
Health Technology
|
| O: 2.62%
H: 2.69%
C: -3.39%
cologuard ces test cancer colorectal cancer
Gritstone Announces First Patient Enrolled for Phase 2/3 Trial Evaluating Individualized Neoantigen Vaccine GRANITE for First Line (1L) Maintenance Treatment of Metastatic, Microsatellite-Stable Colorectal Cancer (MSS-CRC)
Published: 2022-01-13 (Crawled : 13:00) - biospace.com/
GRTS | $0.7477 0.54% 600K
|
Health Technology
|
| O: -6.43%
H: 1.98%
C: -3.82%
satellite treatment phase 2 rosa phase 2/3 trial cancer colorectal cancer vaccine als enroll
Guardant Health Reaches Target Enrollment of 12,750 Patients in ECLIPSE Pivotal Study for its LUNAR™-2 Blood Test to Detect Colorectal Cancer
Published: 2021-12-17 (Crawled : 13:30) - biospace.com/
GH M | $16.305 -2.19% 380K
|
Health Services
|
| O: -0.78%
H: 0.0%
C: 0.0%
health blood test cancer colorectal cancer enroll
Tonix Pharmaceuticals Announces Research Collaboration with Columbia University to Study Recombinant Trefoil Factor 2 (rTFF2)-Based Therapy (TNX-1700) for Gastric and Colorectal Cancers
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
tnx-1700 als research therapy collaboration cancer colorectal cancer
Cardiff Oncology Announces Upcoming Presentation on Lead KRAS-mutated Metastatic Colorectal Cancer Program at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Published: 2021-12-10 (Crawled : 14:30) - biospace.com/
CRDF | $4.36 -0.23% 240K
|
Health Services
|
| O: 1.9%
H: 0.0%
C: 0.0%
symposium gastrointestinal presentation test cancer colorectal cancer
Mainz Biomed Launches Ecommerce Store for ColoAlert to Assist Patient Access during Covid-19 PandemicAt-home Colorectal Cancer Diagnostic Test Now Available Online in Germany
Published: 2021-12-07 (Crawled : 14:00) - biospace.com/
MYNZ | $0.89 -1.55% 33K
|
|
| O: -2.11%
H: 2.84%
C: 1.23%
diagnostic covid germany test cancer colorectal cancer store
HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer
Published: 2021-12-06 (Crawled : 01:00) - globenewswire.com
HCM | $16.53 1.04% 19K
|
Health Technology
|
| O: -7.75%
H: 0.0%
C: 0.0%
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -11.5%
H: 0.0%
C: 0.0%
trial cancer colorectal cancer enroll
Global Lumakras Drug Clinical Insight & Sales Forecast Report 2021-2026: Market Opportunities in NSCLC Targeting Lumakras & Colorectal Cancer Targeting Lumakras
Published: 2021-11-25 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
| Email alert
Add to watchlist
sales cancer colorectal cancer drug
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening
Published: 2021-11-19 (Crawled : 13:30) - globenewswire.com
BMRA | $0.76 12K
|
Health Technology
|
| O: 0.42%
H: 6.28%
C: 6.28%
cancer colorectal cancer
Study Shows Guardant360® Liquid Biopsy Test Helps Guide Treatment for Patients with HER2-Driven Metastatic Colorectal Cancer
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
GH M | $16.305 -2.19% 380K
|
Health Services
|
| O: 0.18%
H: 1.32%
C: 1.27%
treatment test cancer colorectal cancer her2+ her2- her2
New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening
Published: 2021-10-25 (Crawled : 23:00) - prnewswire.com
EXAS | $61.67 -2.85% 700K
|
Health Technology
|
| O: 0.78%
H: 2.8%
C: 0.5%
cancer colorectal cancer
In-Vitro Colorectal Cancer Screening Tests Market revenue to cross USD 1.12 Bn by 2027: Global Market Insights Inc.
Published: 2021-10-20 (Crawled : 12:00) - prnewswire.com
EXAS | $61.67 -2.85% 700K
|
Health Technology
|
| O: 0.29%
H: 0.17%
C: -1.15%
OCX J | $2.5 -2.34% 32K
|
Health Technology
|
| O: -0.31%
H: 6.21%
C: 3.73%
test cancer colorectal cancer in vitro
BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients
Published: 2021-10-01 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -8.06%
H: 3.28%
C: 1.51%
phase 2 immunotherapy therapy cancer colorectal cancer trial
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.